September 25, 2012

Vanderbilt University and Bristol-Myers Squibb have signed a collaboration agreement for the discovery, development and commercialization of novel therapies acting on the mGluR4 glutamate receptor, known as positive allosteric modulators, or PAMs, for the treatment of Parkinson's disease. Read more...

HR website now features "live chat"


Vanderbilt employees now have another way to contact Human Resources: they can "live chat" with service representatives at the Employee Service Center. Read more...

Discovery Lecture Thursday, Sept. 27, to focus on mechanisms of fear


Psychiatrist and fear researcher Kerry Ressler, M.D., Ph.D., will deliver the next Flexner Discovery Lecture on Thursday, Sept. 27. His talk, "Fear from Mice to Men: Implications for PTSD and Other Disorders of Fear and Anxiety," will begin at 4 p.m., in 208 Light Hall. Read more...

Occupational Health offers flu shots at Children's Hospital Thursday, Sept. 27


The Occupational Health Clinic will be offering flu shots at the Monroe Carell Jr. Children's Hospital at Vanderbilt on Thursday, Sept. 27, from 7 to 10 a.m. in room 2104. Read more...

From Vanderbilt Medicine: "The Amazing Life and Memory of H.K. Derryberry"


What happened to H.K.'s brain as he fought for survival left him with deficits but may also have bestowed an amazing gift: perfect memory of everything that has ever happened to him. A video produced by Carole Bartoo accompanies the written story by Leslie Hill. Read more...

LifeFlight goes pink for breast cancer awareness


Vanderbilt LifeFlight is going pink during October to show its support for breast cancer awareness. LifeFlight medical crews will wear a special pink name badge on their flight suits and other staff will wear pink golf shirts. Read more...